SSR2(a) receptor expression and adrenergic/cholinergic characteristics in differentiated SH-SY5Y cells

Neurochemical Research

Volumn 28, Issue 3-4, 2003, Pages 449-460

  Hashemi, Sayed Hossein ^a   Li, Jia Yi ^a   Ahlman, Håkan ^a   Dahlström, Annica ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Differentiation; Immunofluorescence; Nuclear SS; SH SY5Y cells; SSR2(a)

Indexed keywords

SOMATOSTATIN RECEPTOR; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR; BIOLOGICAL MARKER; CATECHOLAMINE; CHOLINE ACETYLTRANSFERASE; MEMBRANE PROTEIN; RETINOIC ACID; SOMATOSTATIN; SOMATOSTATIN RECEPTOR SST2A;

ARTICLE; CATECHOLAMINERGIC SYSTEM; CELL DIFFERENTIATION; CELL LINE; CELL NUCLEUS; CHOLINERGIC SYSTEM; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NEUROBLASTOMA CELL; PRIORITY JOURNAL; SYNAPSE VESICLE; CELL CULTURE; GENE EXPRESSION; GENETICS; METABOLISM; NEUROBLASTOMA; PATHOLOGY;

BIOLOGICAL MARKERS; CATECHOLAMINES; CELL DIFFERENTIATION; CHOLINE O-ACETYLTRANSFERASE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; NEUROBLASTOMA; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; SYNAPTIC VESICLES; SYNAPTOPHYSIN; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0037375480     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022848718109     Document Type: Article

References (33)

1. Reubi, J. C., Schaer, J. C., Markwalder, R., Waser, B., Horisberger, U., and Laissue, J. 1997. Distribution of somatostatin receptors in normal and neoplastic human tissues: Recent advances and potential relevance. Yale J. Biol. Med. 70:471-479.
2. Patel, Y. C. 1999. Somatostatin and its receptor family. Front Neuroendocrinol. 20:157-198.
3. Raulf, F., Perez, J., Hoyer, D., and Bruns, C. 1994. Differential expression of five somatostatin receptor subtypes, SSTR1-5, in the CNS and peripheral tissue. Digestion 55:46-53.
4. Epelbaum, J., Bertherat, J., Prevost, G., Kordon, C., Meyerhof, W., Wulfsen, I., Richter, D., and Plouin, P. F. 1995. Molecular and pharmacological characterization of somatostatin receptor subtypes in adrenal, extraadrenal, and malignant pheochromocytomas. J. Clin. Endocrinol. Metab. 80:1837-1844.
5. Vanetti, M., Kouba, M., Wang, X., Vogt, G., and Hollt, V. 1992. Cloning and expression of a novel mouse somatostatin receptor (SSTR2B). FEBS Lett. 311:290-294.
6. Patel, Y. C., Greenwood, M., Kent, G., Panetta, R., and Srikant, C. B. 1993. Multiple gene transcripts of the somatostatin receptor SSTR2: Tissue selective distribution and cAMP regulation. Biochem. Biophys. Res. Com. 192:288-294.
7. Biedler, J. L., Roffler-Tarlov, S., Schachner, M., and Freedman, L. S. 1978. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 38:3751-3757.
8. Biedler, J. L., Helson, L., and Spengler, B. A. 1973. Morphology and growth, tumorgenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 33:2643-2652.
9. Goodall, A.R., Danks, K., Walker, J. H., Ball, S. G., and Vaughan, P. F. 1997. Occurrence of two types of secretory vesicles in the human neuroblastoma SH-SY5Y. J. Neurochem. 68:1542-1552.
10. Ciccarone, V., Spengler, B. A., Meyers, M. B., Biedler, J. L., and Ross, R. A. 1989. Phenotypic diversification in human neuroblastoma cells: Expression of distinct neural crest lineage. Cancer Res. 49:219-225.
11. Spinelli, W. 1982. Effects of phorbol ester tumor promoters and nerve growth factor on neurite outgrowth in cultured human neuroblastoma cells. Cancer Res. 42:5067-5073.
12. Påhlman, S., Ruusala, A. I., Abrahamsson, L., Mattsson, M. E., and Esscher, T. 1984. Retinoic acid-induced differentiation of cultured human neuroblastoma cells: A comparison with phorbolester-induced differentiation. Cell Differ. 14:135-144.
13. Påhlman, S., Mamaeva, S., Meyerson, G., Mattsson, M. E., Bjelfman, C., Ortoft, E., and Hammerling, U. 1990. Human neuroblastoma cells in culture: A model for neuronal cell differentiation and function. Acta Physiol. Scand. (Suppl.) 592:25-37.
14. Goldstein, M., Fuxe, K., and Hokfelt, T. 1972. Characterization and tissue localization of catecholamine synthesizing enzymes. Pharmacol. Rev. 24:293-309.
15. Peter, D., Liu, Y., Sternini, C., de Giorgio, R., Brecha, N., and Edwards, R. H. 1995. Differential expression of two vesicular monoamine transporters. J. Neurosci. 15:6179-6188.
16. Buckley, K. and Kelly, R. B. 1985. Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells. J. Cell Biol. 100:1284-1294.
17. Jahn, R., Schiebler, W., Ouimet, C., and Greengard, P. 1985. A 38,000-dalton membrane protein (p38) present in synaptic vesicles. Proc. Natl. Acad. Sci. USA 82:4137-4141.
18. Schindler, M., Sellers, L. A., Humphrey, P. P., and Emson, P. C. 1997. Immunohistochemical localization of the somatostatin SST2(A) receptor in the rat brain and spinal cord. Neuroscience 76:225-240.
19. Chomczynski, P. and Sacchi, N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
20. 111In-DTPA-D-Phel-octreotide binding and somatostatin receptor subtypes in thyroid tumors. J. Nucl. Med. 41:636-642.
21. Agoston, D. V., Colburn, S., Krajniak, K. G., and Waschek, J. A. 1992. Distinct regulation of vasoactive intestinal peptide (VIP) expression at mRNA and peptide levels in human neuroblastoma cells. Neurosci. Lett. 139:213-216.
22. Pence, J. C. and Shorter, N. A. 1992. Autoregulation of neuroblastoma growth by vasoactive intestinal peptide. J. Pediatr. Surg. 27:935-943.
23. LoPresti. P., Poluha, W., Poluha, D. K., Drinkwater, E., and Ross, A. H. 1992. Neuronal differentiation triggered by blocking cell proliferation. Cell Growth. Differ. 3:627-635.
24. Zadina, J. E., Chang, S. L., Ge, L. J., and Kastin, A. J. 1993. Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells. J. Pharmacol. Exp. Ther. 265:254-262.
25. Hornick, C. A., Anthony, C. T., Hughey, S., Gebhardt, B. M., Espenan, G. D., and Woltering, E. A. 2000. Progressive nuclear translocation of somatostatin analogs. J. Nucl. Med. 41:1256-1263.
26. Raper, S. E., Burwen, S. J., Barker, M. E., and Jones, A. L. 1987. Translocation of epidermal growth factor to the hepatocyte nucleus during rat liver regeneration. Gastroenterology 2:1243-1250.
27. Björklund, S. and Kim, Y. J. 1996. Mediator of transcriptional regulation. Trends Biochem. Sci. 21:335-337.
28. Henderson, J. E. 1997. Nuclear targeting of secretory proteins, Mol. Cell Endocrinol. 129:1-5.
29. Mitchell, P. J. and Tjian, R. 1989. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 245:371-378.
30. Nilsson, C. L., Murphy, C. M., and Ekman, R. 1997. Isolation and characterization of proteins from human lymphocyte nuclei using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and post-source decay analysis. Rapid Commun. Mass. Spectrom 11:610-612.
31. Blomqvist, M., Bergquist, J., Westman, A., Hakansson, K., Hakansson, P., Fredman, P., and Ekman, R. 1999. Identification of defensins in human lymphocyte nuclei. Eur. J. Biochem. 263:312-318.
32. Ekman, R., Gobom, J., Persson, R., Mecocci, P., and Nilsson, C. L. 2001. Arginine vasopressin in the cytoplasm and nuclear fraction of lymphocytes from healthy donors and patients with depression or schizophrenia. Peptides 22:67-72.
33. Bergquist, J. and Ekman, R. 2001. Future aspects of psychoneuroimmunology: Lymphocytes peptides reflecting psychiatriatic disorders by mass spectrometry. Arch Phys. Biochem. 109:369-371.